Ronan Smith, a postdoctoral research fellow at Adelaide University, has been awarded the prestigious Physics in Medicine & Biology (PMB) Early Career Researcher Award for his groundbreaking work in X-ray velocimetry (XV). This award recognizes the best paper in PMB's 2025 Early Career Researcher Focus Collection, and Smith's research has made significant strides in understanding lung function and treatment options for emphysema.
Unlocking the Power of XV Imaging
Smith's research focuses on XV, a novel imaging technique that utilizes X-rays to track lung motion during breathing and create detailed 3D maps of local ventilation. In his award-winning paper, "Visualising ventilation changes following endobronchial valve placement with x-ray velocimetry functional lung imaging," Smith explores the potential of XV to detect changes in lung function after the insertion of endobronchial valves (EBVs).
EBVs are life-changing devices used to treat emphysema, a condition that damages the air sacs in the lungs, making breathing difficult. By placing these valves, airflow is redirected away from damaged areas, allowing the rest of the lung to function more effectively. Smith's research highlights the importance of accurate assessment of EBV placement, as it can significantly impact treatment outcomes.
The Dynamic Nature of the Lungs
What makes XV imaging so powerful is its ability to visualize and quantify lung dynamics. Unlike traditional CT scans, which only measure structural changes, XV imaging provides real-time insights into airflow patterns. Smith explains, "The lungs are a dynamic organ, constantly moving. XV velocimetry allows us to see exactly where air is flowing, providing an instant visual representation of airflow changes. This is crucial for understanding the clinical impact of EBV placement."
In Vivo Demonstration and Software Analysis
To demonstrate the potential of XV, Smith and his team conducted a pilot study on healthy sheep, which have lungs similar in size to humans. They performed XV imaging before and after inserting EBVs, using specialized software from 4DMedical to correlate motion data with CT scans. This software creates 3D maps of ventilation, allowing researchers to measure specific ventilation and heterogeneity across lung regions.
The results were remarkable. XV imaging successfully visualized and quantified the reduction in airflow to areas downstream of the valves, even in regions where CT scans showed no collapse. This non-invasive approach provides a more comprehensive understanding of lung function changes, which is essential for improving treatment strategies.
Future Applications and Impact
Since the publication of his paper, Smith has been exploring various applications of XV imaging. He is working with an interdisciplinary team to study lung function changes in different diseases, aiming to understand the underlying mechanisms and evaluate treatment outcomes. Additionally, Smith is leading the world's first pediatric clinical trial of XV imaging, examining its feasibility in children with cystic fibrosis.
The implications of this research are far-reaching. By improving the accuracy of EBV placement and understanding lung function changes, Smith's work has the potential to revolutionize treatment options for emphysema patients. The ability to visualize airflow changes non-invasively is a significant advancement in medical imaging, offering new possibilities for personalized medicine.
Personal Reflection and Future Endeavors
Smith's achievement of winning the PMB Early Career Researcher Award is a testament to his dedication and the impact of his research. He expresses his excitement, stating, "It feels like the perfect award for a physicist working in medicine/biology. It's a validation of our efforts and a powerful tool to secure funding for continued research."
Looking ahead, Smith is also developing his own research on dark-field X-ray imaging, another innovative X-ray technique. His passion for pushing the boundaries of medical imaging is evident, and his contributions to the field are sure to have a lasting impact on our understanding of lung health and treatment.
